# FDA recall D-1043-2014

> **Actavis Inc** · Class III · drug recall initiated 2013-11-15.

## Product

BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b) 90 count bottle (NDC 0591-3331-19), c) 500 count bottle (NDC 0591-3331-05),  Manufactactred By: Watson Laboratories, Inc. Corona, CA 92880

## Reason for recall

Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-1043-2014
- **Recalling firm:** Actavis Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-11-15
- **Report date:** 2014-02-05
- **Termination date:** 2015-06-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1043-2014

## Citation

> AI Analytics. FDA recall D-1043-2014. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1043-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*